Respiratory Diagnostics Market Size, Share, and Outlook, H2-2025 Report- By Products and Services (Instruments & Devices, Assays & Reagents, Services & Software), By Test (Mechanical Tests, Osa Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests
Description
Respiratory Diagnostics Market Outlook
The global Respiratory Diagnostics Market Size is valued at $6.8 Billion in 2025 and is forecast to reach $10.5 Billion in 2032 at a CAGR of 6.4%.
The Respiratory Diagnostics Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Respiratory Diagnostics Market segments across 22 countries from 2021 to 2032. Key segments covered include By Products and Services (Instruments & Devices, Assays & Reagents, Services & Software), By Test (Mechanical Tests, Osa Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests), By Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others), By End-User (Hospitals and Clinics, Diagnostics Laboratories, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Respiratory Diagnostics Market Insights, 2025
The respiratory diagnostics market is rapidly evolving to address the increasing burden of chronic and infectious respiratory diseases. Innovations in molecular diagnostics, point-of-care testing, and multiplex assays enable fast detection of pathogens such as influenza, RSV, and SARS-CoV-2, as well as biomarkers for asthma and COPD. AI-driven imaging tools and smart spirometry devices are enhancing accuracy, speed, and predictive capabilities. Integration with telehealth platforms and mobile health solutions allows remote monitoring and timely clinical intervention. The expansion of newborn and occupational respiratory screening programs is further driving market growth. Regulatory approvals and reimbursement policies are facilitating the adoption of innovative diagnostic tools. Research is focusing on multi-analyte panels, high-throughput testing, and personalized disease monitoring. Market participants are increasingly emphasizing cost-effective, patient-friendly, and non-invasive diagnostics. Overall, the market is moving toward a combination of precision, automation, and real-time data analysis.
Five Trends Shaping the Global Respiratory Diagnostics Market in 2025 and Beyond
The global Respiratory Diagnostics Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Respiratory Diagnostics Industry?
The Respiratory Diagnostics Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Respiratory Diagnostics Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Respiratory Diagnostics Market Segment Insights
The Respiratory Diagnostics Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Products and Services (Instruments & Devices, Assays & Reagents, Services & Software), By Test (Mechanical Tests, Osa Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests), By Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others), By End-User (Hospitals and Clinics, Diagnostics Laboratories, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Respiratory Diagnostics Industry Value Chain
The chapter identifies potential companies and their operations across the global Respiratory Diagnostics Industry ecosystem. It assists decision-makers in evaluating global Respiratory Diagnostics Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Respiratory Diagnostics Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Respiratory Diagnostics Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Respiratory Diagnostics Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Respiratory Diagnostics Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Respiratory Diagnostics Market.
Europe Respiratory Diagnostics Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Respiratory Diagnostics Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Respiratory Diagnostics Industry competitiveness. The report analyses the key Respiratory Diagnostics Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Respiratory Diagnostics Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Respiratory Diagnostics Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Respiratory Diagnostics Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Respiratory Diagnostics Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Respiratory Diagnostics Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Respiratory Diagnostics Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, BIThe respiratory diagnostics market is rapidly evolving to address the increasing burden of chronic and infectious respiratory diseases. Innovations in molecular diagnostics, point-of-care testing, and multiplex assays enable fast detection of pathogens such as influenza, RSV, and SARS-CoV-2, as well as biomarkers for asthma and COPD. AI-driven imaging tools and smart spirometry devices are enhancing accuracy, speed, and predictive capabilities. Integration with telehealth platforms and mobile health solutions allows remote monitoring and timely clinical intervention. The expansion of newborn and occupational respiratory screening programs is further driving market growth. Regulatory approvals and reimbursement policies are facilitating the adoption of innovative diagnostic tools. Research is focusing on multi-analyte panels, high-throughput testing, and personalized disease monitoring. Market participants are increasingly emphasizing cost-effective, patient-friendly, and non-invasive diagnostics. Overall, the market is moving toward a combination of precision, automation, and real-time data analysis. Healthcare, Briota Technologies Private Ltd, Compumedics Ltd, GE Healthcare, Hologic Inc, Koninklijke Philips N.V., Löwenstein Medical Technology, ndd Medizintechnik AG, Nihon Kohden Corp, ProAxsis Ltd, QIAGEN N.V., ResMed Inc, Revvity Inc, SDI Diagnostics Inc, Seegene Inc, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc, VisBy Medical Inc, Vitalograph Ltd, Vyaire Medical Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Respiratory Diagnostics Market Scope
Leading Segments
By Products and Services
Instruments & Devices
Assays & Reagents
Services & Software
By Test
Mechanical TestsPulmonary Function Tests Spirometry Peak Flow Test
Osa Diagnostic Tests
Imaging TestsX-Ray Computed Tomography Magnetic Resonance Imaging (MRI) Positron Emission Tomography (PET) Others
Traditional Diagnostic TestsImmunodiagnostics Biochemical Tests Microscopy
Molecular Diagnostic TestsPCR Nucleic Acid Amplification Test In Situ Hybridization DNA Sequencing & Next-Generation Sequencing (NGS) Microarrays Others
By Indication
Tuberculosis
Asthma
Lung Cancer
Chronic Obstructive Pulmonary Disease
Others
By End-User
Hospitals and Clinics
Diagnostics Laboratories
Others
Leading Companies
Abbott Laboratories
Becton, Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories Inc
BIThe respiratory diagnostics market is rapidly evolving to address the increasing burden of chronic and infectious respiratory diseases. Innovations in molecular diagnostics, point-of-care testing, and multiplex assays enable fast detection of pathogens such as influenza, RSV, and SARS-CoV-2, as well as biomarkers for asthma and COPD. AI-driven imaging tools and smart spirometry devices are enhancing accuracy, speed, and predictive capabilities. Integration with telehealth platforms and mobile health solutions allows remote monitoring and timely clinical intervention. The expansion of newborn and occupational respiratory screening programs is further driving market growth. Regulatory approvals and reimbursement policies are facilitating the adoption of innovative diagnostic tools. Research is focusing on multi-analyte panels, high-throughput testing, and personalized disease monitoring. Market participants are increasingly emphasizing cost-effective, patient-friendly, and non-invasive diagnostics. Overall, the market is moving toward a combination of precision, automation, and real-time data analysis. Healthcare
Briota Technologies Private Ltd
Compumedics Ltd
GE Healthcare
Hologic Inc
Koninklijke Philips N.V.
Löwenstein Medical Technology
ndd Medizintechnik AG
Nihon Kohden Corp
ProAxsis Ltd
QIAGEN N.V.
ResMed Inc
Revvity Inc
SDI Diagnostics Inc
Seegene Inc
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc
VisBy Medical Inc
Vitalograph Ltd
Vyaire Medical Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Respiratory Diagnostics Market Size is valued at $6.8 Billion in 2025 and is forecast to reach $10.5 Billion in 2032 at a CAGR of 6.4%.
The Respiratory Diagnostics Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Respiratory Diagnostics Market segments across 22 countries from 2021 to 2032. Key segments covered include By Products and Services (Instruments & Devices, Assays & Reagents, Services & Software), By Test (Mechanical Tests, Osa Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests), By Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others), By End-User (Hospitals and Clinics, Diagnostics Laboratories, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Respiratory Diagnostics Market Insights, 2025
The respiratory diagnostics market is rapidly evolving to address the increasing burden of chronic and infectious respiratory diseases. Innovations in molecular diagnostics, point-of-care testing, and multiplex assays enable fast detection of pathogens such as influenza, RSV, and SARS-CoV-2, as well as biomarkers for asthma and COPD. AI-driven imaging tools and smart spirometry devices are enhancing accuracy, speed, and predictive capabilities. Integration with telehealth platforms and mobile health solutions allows remote monitoring and timely clinical intervention. The expansion of newborn and occupational respiratory screening programs is further driving market growth. Regulatory approvals and reimbursement policies are facilitating the adoption of innovative diagnostic tools. Research is focusing on multi-analyte panels, high-throughput testing, and personalized disease monitoring. Market participants are increasingly emphasizing cost-effective, patient-friendly, and non-invasive diagnostics. Overall, the market is moving toward a combination of precision, automation, and real-time data analysis.
Five Trends Shaping the Global Respiratory Diagnostics Market in 2025 and Beyond
The global Respiratory Diagnostics Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Respiratory Diagnostics Industry?
The Respiratory Diagnostics Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Respiratory Diagnostics Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Respiratory Diagnostics Market Segment Insights
The Respiratory Diagnostics Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Products and Services (Instruments & Devices, Assays & Reagents, Services & Software), By Test (Mechanical Tests, Osa Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests), By Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others), By End-User (Hospitals and Clinics, Diagnostics Laboratories, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Respiratory Diagnostics Industry Value Chain
The chapter identifies potential companies and their operations across the global Respiratory Diagnostics Industry ecosystem. It assists decision-makers in evaluating global Respiratory Diagnostics Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Respiratory Diagnostics Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Respiratory Diagnostics Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Respiratory Diagnostics Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Respiratory Diagnostics Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Respiratory Diagnostics Market.
Europe Respiratory Diagnostics Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Respiratory Diagnostics Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Respiratory Diagnostics Industry competitiveness. The report analyses the key Respiratory Diagnostics Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Respiratory Diagnostics Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Respiratory Diagnostics Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Respiratory Diagnostics Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Respiratory Diagnostics Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Respiratory Diagnostics Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Respiratory Diagnostics Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, BIThe respiratory diagnostics market is rapidly evolving to address the increasing burden of chronic and infectious respiratory diseases. Innovations in molecular diagnostics, point-of-care testing, and multiplex assays enable fast detection of pathogens such as influenza, RSV, and SARS-CoV-2, as well as biomarkers for asthma and COPD. AI-driven imaging tools and smart spirometry devices are enhancing accuracy, speed, and predictive capabilities. Integration with telehealth platforms and mobile health solutions allows remote monitoring and timely clinical intervention. The expansion of newborn and occupational respiratory screening programs is further driving market growth. Regulatory approvals and reimbursement policies are facilitating the adoption of innovative diagnostic tools. Research is focusing on multi-analyte panels, high-throughput testing, and personalized disease monitoring. Market participants are increasingly emphasizing cost-effective, patient-friendly, and non-invasive diagnostics. Overall, the market is moving toward a combination of precision, automation, and real-time data analysis. Healthcare, Briota Technologies Private Ltd, Compumedics Ltd, GE Healthcare, Hologic Inc, Koninklijke Philips N.V., Löwenstein Medical Technology, ndd Medizintechnik AG, Nihon Kohden Corp, ProAxsis Ltd, QIAGEN N.V., ResMed Inc, Revvity Inc, SDI Diagnostics Inc, Seegene Inc, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc, VisBy Medical Inc, Vitalograph Ltd, Vyaire Medical Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Respiratory Diagnostics Market Scope
Leading Segments
By Products and Services
Instruments & Devices
Assays & Reagents
Services & Software
By Test
Mechanical Tests
Osa Diagnostic Tests
Imaging Tests
Traditional Diagnostic Tests
Molecular Diagnostic Tests
By Indication
Tuberculosis
Asthma
Lung Cancer
Chronic Obstructive Pulmonary Disease
Others
By End-User
Hospitals and Clinics
Diagnostics Laboratories
Others
Leading Companies
Abbott Laboratories
Becton, Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories Inc
BIThe respiratory diagnostics market is rapidly evolving to address the increasing burden of chronic and infectious respiratory diseases. Innovations in molecular diagnostics, point-of-care testing, and multiplex assays enable fast detection of pathogens such as influenza, RSV, and SARS-CoV-2, as well as biomarkers for asthma and COPD. AI-driven imaging tools and smart spirometry devices are enhancing accuracy, speed, and predictive capabilities. Integration with telehealth platforms and mobile health solutions allows remote monitoring and timely clinical intervention. The expansion of newborn and occupational respiratory screening programs is further driving market growth. Regulatory approvals and reimbursement policies are facilitating the adoption of innovative diagnostic tools. Research is focusing on multi-analyte panels, high-throughput testing, and personalized disease monitoring. Market participants are increasingly emphasizing cost-effective, patient-friendly, and non-invasive diagnostics. Overall, the market is moving toward a combination of precision, automation, and real-time data analysis. Healthcare
Briota Technologies Private Ltd
Compumedics Ltd
GE Healthcare
Hologic Inc
Koninklijke Philips N.V.
Löwenstein Medical Technology
ndd Medizintechnik AG
Nihon Kohden Corp
ProAxsis Ltd
QIAGEN N.V.
ResMed Inc
Revvity Inc
SDI Diagnostics Inc
Seegene Inc
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc
VisBy Medical Inc
Vitalograph Ltd
Vyaire Medical Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
200 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Respiratory Diagnostics Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Respiratory Diagnostics Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Respiratory Diagnostics Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Respiratory Diagnostics Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Respiratory Diagnostics Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Products and Services
- Instruments & Devices
- Assays & Reagents
- Services & Software
- By Test
- Mechanical Tests
- -Pulmonary Function Tests
- -Spirometry
- -Peak Flow Test
- Osa Diagnostic Tests
- Imaging Tests
- -X-Ray
- -Computed Tomography
- -Magnetic Resonance Imaging (MRI)
- -Positron Emission Tomography (PET)
- -Others
- Traditional Diagnostic Tests
- -Immunodiagnostics
- -Biochemical Tests
- -Microscopy
- Molecular Diagnostic Tests
- -PCR
- -Nucleic Acid Amplification Test
- -In Situ Hybridization
- -DNA Sequencing & Next-Generation Sequencing (NGS)
- -Microarrays
- -Others
- By Indication
- Tuberculosis
- Asthma
- Lung Cancer
- Chronic Obstructive Pulmonary Disease
- Others
- By End-User
- Hospitals and Clinics
- Diagnostics Laboratories
- Others
- 6. Global Respiratory Diagnostics Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Respiratory Diagnostics Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Respiratory Diagnostics Market Trends and Growth Opportunities
- 6.2.1 North America Respiratory Diagnostics Market Outlook by Type
- 6.2.2 North America Respiratory Diagnostics Market Outlook by Application
- 6.3 North America Respiratory Diagnostics Market Outlook by Country
- 6.3.1 The US Respiratory Diagnostics Market Outlook, 2021- 2032
- 6.3.2 Canada Respiratory Diagnostics Market Outlook, 2021- 2032
- 6.3.3 Mexico Respiratory Diagnostics Market Outlook, 2021- 2032
- 7. Europe Respiratory Diagnostics Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Respiratory Diagnostics Market Trends and Growth Opportunities
- 7.2.1 Europe Respiratory Diagnostics Market Outlook by Type
- 7.2.2 Europe Respiratory Diagnostics Market Outlook by Application
- 7.3 Europe Respiratory Diagnostics Market Outlook by Country
- 7.3.2 Germany Respiratory Diagnostics Market Outlook, 2021- 2032
- 7.3.3 France Respiratory Diagnostics Market Outlook, 2021- 2032
- 7.3.4 The UK Respiratory Diagnostics Market Outlook, 2021- 2032
- 7.3.5 Spain Respiratory Diagnostics Market Outlook, 2021- 2032
- 7.3.6 Italy Respiratory Diagnostics Market Outlook, 2021- 2032
- 7.3.7 Russia Respiratory Diagnostics Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Respiratory Diagnostics Market Outlook, 2021- 2032
- 8. Asia Pacific Respiratory Diagnostics Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Respiratory Diagnostics Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Respiratory Diagnostics Market Outlook by Type
- 8.2.2 Asia Pacific Respiratory Diagnostics Market Outlook by Application
- 8.3 Asia Pacific Respiratory Diagnostics Market Outlook by Country
- 8.3.1 China Respiratory Diagnostics Market Outlook, 2021- 2032
- 8.3.2 India Respiratory Diagnostics Market Outlook, 2021- 2032
- 8.3.3 Japan Respiratory Diagnostics Market Outlook, 2021- 2032
- 8.3.4 South Korea Respiratory Diagnostics Market Outlook, 2021- 2032
- 8.3.5 Australia Respiratory Diagnostics Market Outlook, 2021- 2032
- 8.3.6 South East Asia Respiratory Diagnostics Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Respiratory Diagnostics Market Outlook, 2021- 2032
- 9. South America Respiratory Diagnostics Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Respiratory Diagnostics Market Trends and Growth Opportunities
- 9.2.1 South America Respiratory Diagnostics Market Outlook by Type
- 9.2.2 South America Respiratory Diagnostics Market Outlook by Application
- 9.3 South America Respiratory Diagnostics Market Outlook by Country
- 9.3.1 Brazil Respiratory Diagnostics Market Outlook, 2021- 2032
- 9.3.2 Argentina Respiratory Diagnostics Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Respiratory Diagnostics Market Outlook, 2021- 2032
- 10. Middle East and Africa Respiratory Diagnostics Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Respiratory Diagnostics Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Respiratory Diagnostics Market Outlook by Type
- 10.2.2 Middle East and Africa Respiratory Diagnostics Market Outlook by Application
- 10.3 Middle East and Africa Respiratory Diagnostics Market Outlook by Country
- 10.3.1 Saudi Arabia Respiratory Diagnostics Market Outlook, 2021- 2032
- 10.3.2 The UAE Respiratory Diagnostics Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Respiratory Diagnostics Market Outlook, 2021- 2032
- 10.3.4 South Africa Respiratory Diagnostics Market Outlook, 2021- 2032
- 10.3.5 Egypt Respiratory Diagnostics Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Respiratory Diagnostics Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Abbott Laboratories
- Becton, Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories Inc
- BIRD Healthcare
- Briota Technologies Private Ltd
- Compumedics Ltd
- GE Healthcare
- Hologic Inc
- Koninklijke Philips N.V.
- Löwenstein Medical Technology
- ndd Medizintechnik AG
- Nihon Kohden Corp
- ProAxsis Ltd
- QIAGEN N.V.
- ResMed Inc
- Revvity Inc
- SDI Diagnostics Inc
- Seegene Inc
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc
- VisBy Medical Inc
- Vitalograph Ltd
- Vyaire Medical Inc
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
